Celgene (CELG) Tops Q1 EPS by 9c, Updates Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. ABBV
5. CL
6. LYB
7. TFII
8. SPY
9. AAPL
10. MRVL

Go back to Celgene (CELG) Tops Q1 EPS by 9c, Updates Guidance

Celgene Reports First Quarter 2018 Operating and Financial Results

May 4, 2018 7:30 AM EDT

Q1:18 total net product sales of $3,531 million, increased 20% Y/Y

Raising full-year 2018 revenue guidance to high end of previous range

Completion of Juno Therapeutics & Impact Biomedicines acquisitions will strengthen pipeline and capabilities

Submission of NDA and MAA for ozanimod in relapsing multiple sclerosis expected in Q1:19

SUMMIT, N.J.--(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) reported net product sales of $3,531 million for the first quarter of 2018, a 20 percent increase from the same period in 2017. Celgene reported first quarter 2018 total... More